306 related articles for article (PubMed ID: 9083481)
21. Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies.
Mugnaini C; Rajamaki S; Tintori C; Corelli F; Massa S; Witvrouw M; Debyser Z; Veljkovic V; Botta M
Bioorg Med Chem Lett; 2007 Oct; 17(19):5370-3. PubMed ID: 17716893
[TBL] [Abstract][Full Text] [Related]
22. Molecular dynamics simulations of the HIV-1 integrase dimerization interface: guidelines for the design of a novel class of integrase inhibitors.
Sippel M; Sotriffer CA
J Chem Inf Model; 2010 Apr; 50(4):604-14. PubMed ID: 20230013
[TBL] [Abstract][Full Text] [Related]
23. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
[TBL] [Abstract][Full Text] [Related]
24. Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitors.
Al-Mawsawi LQ; Dayam R; Taheri L; Witvrouw M; Debyser Z; Neamati N
Bioorg Med Chem Lett; 2007 Dec; 17(23):6472-5. PubMed ID: 17950601
[TBL] [Abstract][Full Text] [Related]
25. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
[TBL] [Abstract][Full Text] [Related]
26. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.
Barreca ML; Ortuso F; Iraci N; De Luca L; Alcaro S; Chimirri A
Biochem Biophys Res Commun; 2007 Nov; 363(3):554-60. PubMed ID: 17889829
[TBL] [Abstract][Full Text] [Related]
27. Novel virtual screening protocol based on the combined use of molecular modeling and electron-ion interaction potential techniques to design HIV-1 integrase inhibitors.
Tintori C; Manetti F; Veljkovic N; Perovic V; Vercammen J; Hayes S; Massa S; Witvrouw M; Debyser Z; Veljkovic V; Botta M
J Chem Inf Model; 2007; 47(4):1536-44. PubMed ID: 17608406
[TBL] [Abstract][Full Text] [Related]
28. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.
Pace P; Spieser SA; Summa V
Bioorg Med Chem Lett; 2008 Jul; 18(14):3865-9. PubMed ID: 18595690
[TBL] [Abstract][Full Text] [Related]
29. A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series.
De Luca L; Barreca ML; Ferro S; Iraci N; Michiels M; Christ F; Debyser Z; Witvrouw M; Chimirri A
Bioorg Med Chem Lett; 2008 May; 18(9):2891-5. PubMed ID: 18417342
[TBL] [Abstract][Full Text] [Related]
30. Rational design of novel diketoacid-containing ferrocene inhibitors of HIV-1 integrase.
da Silva CH; Del Ponte G; Neto AF; Taft CA
Bioorg Chem; 2005 Aug; 33(4):274-84. PubMed ID: 16023487
[TBL] [Abstract][Full Text] [Related]
31. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
[TBL] [Abstract][Full Text] [Related]
32. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors.
Gupta P; Roy N; Garg P
Eur J Med Chem; 2009 Nov; 44(11):4276-87. PubMed ID: 19647906
[TBL] [Abstract][Full Text] [Related]
33. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.
Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459
[TBL] [Abstract][Full Text] [Related]
34. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
Barreca ML; Ferro S; Rao A; De Luca L; ZappalĂ M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
[TBL] [Abstract][Full Text] [Related]
35. Pharmacophore-based database mining for probing fragmental drug-likeness of diketo acid analogues.
Bak A; Magdziarz T; Polanski J
SAR QSAR Environ Res; 2012 Jan; 23(1-2):185-204. PubMed ID: 22292781
[TBL] [Abstract][Full Text] [Related]
36. Ethyl malonate amides: a diketo acid offspring fragment for HIV integrase inhibition.
Serafin K; Mazur P; Bak A; Laine E; Tchertanov L; Mouscadet JF; Polanski J
Bioorg Med Chem; 2011 Aug; 19(16):5000-5. PubMed ID: 21767953
[TBL] [Abstract][Full Text] [Related]
37. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
[TBL] [Abstract][Full Text] [Related]
38. De novo design and synthesis of HIV-1 integrase inhibitors.
Makhija MT; Kasliwal RT; Kulkarni VM; Neamati N
Bioorg Med Chem; 2004 May; 12(9):2317-33. PubMed ID: 15080929
[TBL] [Abstract][Full Text] [Related]
39. Pharmacophore development and docking studies of the hiv-1 integrase inhibitors derived from N-methylpyrimidones, Dihydroxypyrimidines, and bicyclic pyrimidinones.
Telvekar VN; Patel KN
Chem Biol Drug Des; 2011 Jul; 78(1):150-60. PubMed ID: 21518263
[TBL] [Abstract][Full Text] [Related]
40. Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors.
de Melo EB; Ferreira MM
Eur J Med Chem; 2009 Sep; 44(9):3577-83. PubMed ID: 19327872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]